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Keratinocyte cell death, whether produced by skin disease or 
by physiologic apoptosis in normal skin, may result in forma-
tion of dermal keratin bodies, consisting mainJy of keratin 
intennediate filament agg,regarcs. Virronectin, a multifunc-
tional plasma and tissue glycoprotein, which inhibits the 
complemenc membrane attac.k complex and promotes cell 
attachment and spreading, is, like amyloid P component, 
associated with keratin bodies in vivo. To investigate a po-
tcnrial role for vitronectin. in the removal of keratin bodies, 
we studied the interaction of virronectin with keratin. inter-
mediate filaments in normal human skin and in Hep-2 cells, 
as well as with isolated keratin intermediate filamem aggre-
gates in vitro. Following pre-incubation of skin sections and 
Hep-2 cells with normal human serum (as a source of vitro-
nectin) , cytoplasmic staining of keratinocytes and of cyto-
skeletal filaments in Hcp-2 cells was observed by immuno-
fluorescence staining with polyclonal and monoclonal 
anti-vitronectin antibodies. Vitronectin binding to keratin 
D ermal keratin (cyroid. colloid. Civatte) bodies occur as a physiologic event due [0 kcratinocyte apoptosis in normal human skin [1 J and are found in increased quantities because of keratinocytf' death in a variery of lymphocyte-mediated skin diseases including li-
chen planus. lupus erythematosus, certain drug eruptions. and cuta-
neous graft-versus-host disease. Keratin bodies are composed 
mainly of keratin intermediate l1lament aggregates (KlFA) {l] and 
are frequently coated with i.mmunoglobulins (especially IgM) and 
the third component of complement (C3) in vivo [2.3J. Keratin 
bodies are thought to be routinely diminated, a process which may 
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AP: 2myloid P component 
EDT A: ethylenedi2mine tecraaccric acid 
FITC: fluorescein isothiocyan2te 
H RP; horseradish peroxid~ 
KIF: keratin intermediate filament(s) 
KIFA: keratin intermediate fiillmem aggreg:ne.s 
PAGE: polyacrylamide gel electrophoresis 
PBS: phosphate buffered saline 
SAP: serum amyloid P component 
SDS: sodium dodecyl sulfate 
intermediate filamenr aggregates extracted from normal 
human epidermis was demonstrated by immunofluorescence 
and by immunoblotting. and was not dependent on comple-
ment activation, because it occurred even when heat-inacti-
vated human serum or C4-de6cient serum was used as a 
source of vitronectin. Amyloid P component shows Ca++--
dependent binding to keratin intermediate filament aggre-
gates. Virronectin binding to keratin intermediate filament 
aggregates does not involve amyloid P componenr because it 
occurred when binding of the latter protein was inhibited by 
EDTA buffer. Moreover, purified vitronectin also bound to 
keratin intermediate filament aggregates ill immunofluores-
cence studies. Virronectin binding to keratin intermediate 
filaments may playa role both in limiting complement-me-
diated tissue damage (because keratin bodies may activate 
complement) and in promoting removal of keratin bodies by 
fibroblasts and/or macrophages. } Invest Dermatol 93:656-
661, 1989 
involve opsonizarion by anti-keratin imcrmedjatt: filament (KlF) 
autoantibodies [2.4 - 6}. acriva rion of the complement cascade [7.B], 
and/ or phagocytosis by macrophages. W e have recently reported 
19] that amyloid P component (AP), which is invariably present in 
normal adult human (issues in non-covalent association with elastic 
fiber microfibrils and is idf'ntical to the normal plasma glycoprotein 
serum amyloid P component (SAP) 110-12]. is also regularly found 
in association with dermal keratin bodies. The significance of rhe 
association between AP and keratin bodies, which occurs as a result 
of Ca++-dependent binding of AP to KlFA [9]. is unknown. 
Vitronecrin. also known as serum-spreading factor. S-protein of 
complement and epibolin [13-17J. is a glycoprotein present not 
only in high concenrration in plasma but also as a normal tissue 
protein. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) of vitronectin consistently identifies two polypeptide 
bands of 75 and 65 kD, which arc thought to be rel:aed to one 
another through proreolysis 113 - 15J. Vitronecrin promotes attach-
ment and spreading of a variery of cell rypes, including fibroblasts 
and epithelial cells i13J, and stimulates migration of rumor cells in 
vitro, indicating a porential physiologic ro le in cel l migration [18]. 
In common wirh other ex tracel lular matrix proteins with adhesive 
properties such as fibronecrin and laminin, vitronectin contains an 
Arg-Gly-Asp (RGD) sequence recognized by a specific receptor 
which belongs to rhe fami ly of cell-surface receptors termed inte-
grins [19J. Vitronectin binds in virro CO glass, and addi rionaJ Iig:ands 
include heparin. glycosaminoglycans 120]. and collagen [21J. Vi-
tronectin may h3ve a regulacory function in complement aerivation 
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and in the coagulation system. It acts as an inhibitor of the mem-
br2ne attack complex of complement by binding to CSb-7 com-
~Iex~ a~d.prevcn ting C9 ~lym~riza tjon .[22.23j. P las,:"a vi tronec-
[In IIlhl\ms the thrombin-antithrombin III reaction and is 
incorpor:aed into a tertiary complex with thrombin and thrombin-
anrithrol11bin UI during coagulation 124]. The binding of platelets 
and endothelial cells to vitronectin indicates that it may playa role 
in platelet aggregation and thrombus formation [25,26]' Vitronec-
rin immunoreacriviry. like [hat of AP (10-12,271 and of decay 
accelerating faeCor (anorher complement inhibitor) 1281, has been 
localiud to elasric [issue fibers in normal and/or diseased human 
skin and other tissues [29 -3 1]. Vitronectin immunoreactivity, 
again like that of AP [9.32.33] . has also been demonstrated in associ-
ation with kera tin bodies in lichen planus. dermal amyloid deposits 
in primary localized cut:meom amyloidosis, and abnormally thick-
ened cutaneous blood vessels in porphyria [3 1 I. 
It has been speculated that the binding of vitronectin [0 keratin 
bodies and other pathologic tISsue deposits may occur purdy as a 
secondary ('vem to acrivation of the complemen! system 131]. Alter-
natively. the association of vi tronectin and keratin bodies ill vivo 
may imply that vitronectin is involved in the processing of extracel-
lular KIF by promoting receptor-mediated adhesion of phagocytic 
cell!!.. We [here-fore investigated the inreraction of vitroncctin with 
keratin filaments in skin sections, in Hep-2 cel ls. and using isolated 
KIFA, with special reference to complement acti vation. In view of 
the co-distribution of vitroneccin and SAP in normal and lesional 
skin, we also studied the interrelationship of the binding chancrer-
isrics of rhese twO proreins. 
MATER1ALS AND METHODS 
Sera and Skin Specimens Human sera were obtained from nor-
mal volunteers and from a patient with hereditary C4-deficicncy 
[34J; se.r;1 were either used immediately or stored al - 20·C until 
used. Normal hurmn skin (punch biopsies and kerarome sect ions) 
was obtained at surgical operations. 
Antisera and C hemical Reagents A murine monoclonal anti· 
body against vitronectin was obtained from Cytotech (San Diego. 
CA). and a polydonal rabbit anti-v irronectin antibody was pre:"pared 
as prC\·jousJy described [291. Fluorescein-conjugated (FITC) rabbit 
ami-human C3 antibody was obtained from Dakopacts (Glostrup. 
Denmark). and monoclonal murine amikera tin antibodies AE-I / 
AE·3 from Hybritech Inc. (San Diego. CA). FITC sheep anti-
mouse' JgGjIgM was obtained from Grub Scandic (Vienna. Aus-
tria), and FITC swine anti-rabbit immunoglobulin , horse radish 
peroxidase-conjugated (HRP-) swine anti-rabbit immunoglobulin. 
and HRP-rabbit anti-mouse immunoglobulin were obtajned from 
Dakopatts. Tbe IgG fraction of rabbit antihuman SAP antibody was 
the kind gift of Professor M.B. Pepys (Immunological Medicine 
Unit, Royal Postgraduate Medical School, London. U.K.). FITC 
goat anri-human SAP was obtained from Atlantic Antibodies (Scar-
borough. ME). 
hnmuno£)uorescence Examination of BiDding of Vitronec· 
tin [0 Normal Human Skin Sections and Hep-2 Cells Six-mi-
crometer vertical cryostat sections of normal human skin and Hep-2 
cdl monolayers (obtained from Kallestad, Austin. TX) grown on 
glass slides were:" incubated with neat normaJ human serum as a 
source of both vitronectin and SAP for 30 min al room temperature. 
In addition, in ocher studies Hep-2 cells were pre-incubated with 
C4-deficient serum or with heat-inactivated serum (56·C for 30 
min) froUl a norma! subject. Th~ substrates were thcn washed ex ten-
sively. The presence or absence of binding of vi tronectin was deter-
mined by immunofluorescence staining. Monodonal ami-
vitrOllectin antibody at a dilution of 1 : 50, or th~ polydonal anti-vi-
tronectin antibody at a di lution of 1: 250. followed by FITC-sheep 
anti-mouse 19GjlgM ar a dilurion of 1 : 20, or FlTC-swine anti-
rabbit immunoglobulin at a dilut.ion of 1 : 20, were used. As a con-
trol rh~ substratcs were stained without pre-incubation with serum. 
arid in a further control anti-vitronectin antibodies were replaced by 
PBS. In order to investigate the Ca++ -dependency of any vitronec-
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rin binding and the relationship of vitronecrin binding to skin with 
rhe known Ca++-dependem binding of SAP <0 K1F [9J. washing of 
the substrates after pre-incubation with serum and all subsequent 
anribody dilutions and washes were carried out using either "cal-
cium buffer" (O.O lM Tris. O. 138M NaCI. 0.002M CaCl,. pH 8.0) 
or "EDTA buffer" (O.Ol M Tris. 0.1 38M Nad. O.OlM EDTA. pH 
8.0). Virronectin binding was detected by immunofl uorescence as 
abolfe. Binding of SAP to KIF was demonstrated by using FITC-
ami-SAP antibody at a dilution of 1 : 20. 
Preparatio n of isolated KIF Aggregates Keratome ~crions of 
nonnal human skin were incubated wi th 0.02M EDT A buffer for 
90 min at 45 °C, and [he epidermis was [hen stripped off the:" derITUs. 
The epidermis was minced and extracted in an 8M urea buffer 
containin g 0.01 M T ris He l (pH 9.0) and O.lM 2-mcrcaptoethanol 
for 4 h at' room temperature 16}. After removal of the cel lular debris 
by cenrrifugation at 19.000 rpm for 1 h. tbe supernatant was dia-
lyzed overnight against 1,000 volumes of phosphatt': buffered saline 
(PBS). pH 7.3. at room temperature. This resulted in the formation 
of a suspension of isolated KlFA . whicb was further purified by 
redissolving in u.rea solution and repeating t.he reconstituuon proce-
duno:. 
Absorption of Vitro nee tin aDd SAP on KlFA Five~milligram 
aliquots of the KIFA suspension were centrifuged. and the pellets 
were incubated with one of the following hurnan serum samples as 
source's of vitronecrin for 2 h at room ccmpt"rature with consta.nt 
agit!ltion b)' end over end rumbling: 1) four different normal human 
sera. 2) a C4-dcficient serum. and 3) hear-inacrivated serum (56·C 
for 30 min) from a normal subject. All sera wt:re used at a dilution of 
1 : 2 in PBS. Following centrifugation. the pellets were washed in 
PBS With constant agitation for 2 h at room temperature and then 
overnight at 4°C. After a furthe r centrifugation. the pellets were 
resuspended in 1 ml of PBS; these suspensions of [ile various KIFA-
setum reaction products were then used for immunofluorescence 
and immunoblotting studies. In ont' experimenc. {he diluent for the 
nonnal human serum and th~ buffer for all subsequent washes 
throughout the absorption procedure was t':ither "calcium buffer' 
or ';EDTA buffer" (see above). The presence or absence of binding 
of vitroneccin from serum [ 0 KIFA was then derennined by immu-
nofluorescence as follows. Drops of the various K.IFA-serum reac-
rion products were air dried on glass sl ides and fixed with acetone 
fo r 5 min:ll room tcmperarure. The' KIFA-serum reaction products 
were th en incubated with monoclonal or polyclonal ami-vitronec~ 
rin anribody as described above (or Immunofluorescence staining of 
ski n sections. The following controls were performed: a) KIFA 
were stained without pre-incubation with serum as above. b) KlFA 
without or c) with pre-incubarion with serum were stained only 
with the FITC-Iabeled second-step antibody. Complement activa-
tion after exposure:" of KIFA to srrum was demonstrated by the 
association of C3 with rhe KIFA. detected by fluorescence with 
FITC anti-C3 antibody at:l dil ution of 1 : 20. Binding of SAP from 
serum to KIFA, as previously reported [9], was similarly demon-
strated by fluorescence of the KIFA-serum reaction product with 
FITC anti-SAP used at a dilution of 1 : 20. 
In a further experiment. drops of the KlFA suspension, unex-
posed m any serum. were air dried on glass slides. fixed with ace-
mne. and then reacted with purified vitronectin (Calbiochem. La 
Jolla. CA) at a concentration of 250 ,um/ ml in PBS for 60 min at 
3rC. After extensive washing. the occurrence of binding of vi-
[ronectin to the KIFA was investigated by immunofluorescence 
using anti-virronectin antibodies as above. 
lm.ntunoblotting 1mmunoblotting was performed essentially as 
prt"viously described [4). Four-hundred microliters of "extraction 
buffer" (0.0625M Tns. 2% sodiunl dodecyl sulfote. 10% glycerol . 
5% 2-merc:lptQerhanol, 0.01 % bromophenol blue. 1 % Triton 
X-IOO) were added to 200~,u1 aliquots of the various KlFA-serum 
reaction products. These samples we.re boiled for 10 min SOS-
PAGE was pe.rformed on 9% or 13% continuous gds using 50 ,uJ of 
the various samples. After transfer to nirroceIJul9se paper, the pro· 
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teins were stained with 0.1 % Fast Green FCF (Biorad l....:abs. Rich-
mond, CA) in order to enable their position on the paper to be 
m.rked by punching the paper with. needle 135] (Fig 4). Kerarin 
filament proteins were then identified by AE- t / AE-3 monoclonal 
murine anti keratin antibodies (dilution 1 : 2.000). followed by HRP 
rabbit anti-mouse immunoglobulin (dilution 1 : 1.000). Vitronectin 
was identified by monoclonal murine anti-virronectin (dilution 
1 : 2.000) or polyclonal rabbit anti-virronectin (di lution 1 : 1,000), 
followed by HRP rabbit anti-mouse immunoglobulin (dilution 
1 : 1,000) or HRP swine ami-rabbit inununoglobulin (dilution 
1: 500). The peroxidase reaction product was visualized using the 
diaminobe.nzidine reaction. As a control for these studies, the first 
antibodies were replaced by washing buffer. The specificity of the 
monoclonal and polydonal anti-vitronectin antibodies was con-
finned in immullobiotting experiments using either 0.3,ug of puri-
fil:U virrouc:ctin or 2.5 ,ul of a 1 : t 5 dilution of normal human serum 
as a source of vitronectin. The presence or absence of SAP in the 
KIFA-serum reaction product was analyzed with rabbit anti-SAP as 
previously described 19]. 
RESULTS 
Immunofluorescence Examination of Binding of Vitronec-
tin to Normal Human Skin Sections and H ep-2 Cells Immu-
nofluorescence staining of normal human skin, following pre-incu-
bation with normal human serum, with ami-vitronectin antibodies 
produced cytoplasmic staining ofkeratinocytes (Fig l A). which was 
absent when the serum pre-incubation was omined (Fig 1 B), in 
addition to fluorescence associated with elastic tissue fibers as pre-
viously reported {29J. There was no fluorescence wben skin was 
pre-incubated with serum and then stained only with the f1uores-
ceinated second-srep antibody. Ca++-dependent binding of SAP 
from serum to ke.ratin filaments, as previously described 19]. was 
demonstrated by cytoplasmic fluorescence of keratinocytes with 
ami-SAP antibody when ami body dilutions and washes were car-
ried out with Ca++buffer but not EDTA buffer. Binding of vitron-
ectin from serum to keratinocytcs occurred using nor only 
Ca++buffer. but also EDTA buffer when SAP was not bound. 
Bright staining of cytoplasmic filaments. as well as of nucleoli , in 
Her-2 cells was observed. following their pre-incubation with nor-
ma human serum, and immunofluorescence sraining with ami-vi-
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rronecrin an ribodies (Fig 2A). In conrrol experiments, in which the 
serum pre-incubation step was omitted, or tbe anti-vitronectin anti-
body was replaced by PBS, no naining of Hep-2 ce ll cytoplasmic 
filaments or nucleoli was detected (Fig 2B). Staining of cytoplasmic 
filamenn; occurred even when the cells were pre-incubated with 
C4-deficienr (Fig 2C) or heat-inactiv:aed serum (Fig W). Binding 
of vitronectin from serum to J-iep-2 cells was Ca++-independ~nt. 
and therefore occurred under conditions which prevent binding of 
SAP. 
lmmun06uorescence Staining of KIFA Pre-incubated with 
Serum KlFA in suspension showed bright globular fluorescence 
with anri-vitronectin antibody following pre-incubation with nor-
mal human serum 35 a source of vitronectin; individual KlFA were 
oudined by ring-like fluorescence. Fluorescence of the KlFA-serum 
reaction rroducr wirh anri-vitroneccin antihody occurred indepen-
dently 0 the presence of Ca++ (Fig 3A .B); binding of SAP from 
serum to KIFA was abolished when EDTA buffer was used, as 
reported 19J. No fluorescence was observed in control studies when 
KlFA were not pre-incubated with serum or when ami-vitroneccin 
antibody was rerlaced by PBS (Fig 3C). Complemenr activation 
after exposure 0 KlFA to normal human serum was demonstrated 
by globular fluorescence of KIF A with FITe anri-C3 antibody but 
was absent when KIFA were pre-incubated with C4-deficient 
serum or heat-inactivated serum (data not shown). Vitronectin 
binding to KIFA was complement-independent. because it occurred 
even when KIFA were pre-incubated wirh C4-ddlcient Serum or 
heat-inacrivated serum (Fig 3D). Moreover, fluorescence of KIF 
with anti-vitronectill antibodies was seen when KIFA were pre-in-
cubated with purified vitronectin (Fig 3E). 
I.m.munoblotting The interaction between vitronecrin and KlFA 
was further investigated by SDS-PAGE and immunoblotting. SDS-
PAGE of KJFA revealed four major protein bands (Fig 4, lant B), 
which were identined as keratin filament proteins by immunoblor-
ting with AE1 / AE3 anrikcratin anribodies (Fig 4.1aru C). The pres-
ence of vitronecrin in all of the normal human serum samples used. 
as well as in the C4-deficiem and heat-inactivated serum, was dem-
onstnned by inununoblorring (data not shown). Immunoblotting of 
KIFA pre~incubated with nonnal human sera (Fig 4, //lll t D) , orwith 
C4-deficie.nt or heat-inactivated serum with anti-virronectin anri-
Figure 1. A: Immunofluorescence staining of normal human sk~n. fol1~wing pre-incu~at~on with nonnal ~u.nun serum: with an~i-vitronectin ant~~ies. 
NOle cytoplasmic st;tining ofkeruinocytcsand fluorescence asSOCiated With dermal dunc tISsue fibers. B: StallllDg ofkeraunocytes IS absent, butcla,mc tissue 
AuoresccncC' persists when skin sections are pre~incuba[ed ..... ith PBS instead of serum (X 250). 
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Fig u reo: 2. Immu,nofluoresccilce staining of Hep-2 cdlll. following pre·lOcub:;aion with norm.a.l human serum with monodotlal anti.vitronecrin antibodies. 
A: NOle bright staining of c)'[oplasmic nbments and nucleoli nOl seeo:ll (B) when th(' Hep--2 cells were pre. incuha[ed with PBS insread of serum. Staining of 
c),tOplasmlc nlamcms and nucleoli occurred even when the cdls were pre-incubated with (C) C4.de6.clcnt serum or (D) heat·inactivared serum IX 500 (A. 
D); X 250 (B. C)]. 
bodies showed strong reactiviry 0(2 bands, which co-migrated with 
the 75- and 65-kD proteins of purified vitronectin (Fig 4, fallt.' E) . 
Figure 4 (lane D) also shows weak muning of KIF proteins. These 
bands also stained with an ri-vitronecrin antibody even when, as a 
conrrol. KIFA had nOt been previously reacted with serum (Fig 4. 
lane F). Thus staining of these bands was most likely due co auman-
tibodies directed against keratin filaments in the murine ascitic fluid 
or the rabbit serum; rabbir sera frequendy contain autoantibodies 
dirf'ctcd Jgainst intermedia te filaments [36J. There was no staining 
of any band when, as a further comrol, the KlFA-serul11 reaction 
product transferred to nitrocellulose was incuba ted onl y with HRP-
rabbi t anti-mouse immunoglobul in antibody (Fig 4. larl f G) . Vi-
tronecrin was detected by imtnu noblorring in the KlFA-scrom reac-
tion product regardless of wh~th er serum di lution and washing of 
the KfFA after incubation with serum were carried out in Ca++ or 
EDTA buffer. By contrast. SAP was shown by immunobiotting to 
bind to KlFA only in the presence ofCa++ as previously reported [91 
(dat:1 not shown). 
DISCUSSION 
In this study we have investigated the recently described associarion 
of vltronectin with keratin bodies in vivo {3 q because th is associa-
tion may be of importance in the processing and removal of extra-
cellular keratin filament material in vivo. W e have shown by im-
munofluorescence that virronectin from serum binds to cytoplasmic 
structures in epidermal kcratinocytes and co cytoskeletal filaments 
in Hcp-2 cells. Fluorescence of dennal clastic tissue was again noted 
with anti-virronectin antibodies as previously reponed [29]; despite 
the in vitro affinity of vitronecnn for collagen (2 11. no binding of 
serum vitronectin to dermal collagen fibers was observed. Because 
SAP binds to DNA and chromatin in vitro [37] (and in view of the 
similar tissue distribution of vitron~ctin and AP in the skin), it is of 
intcrest that nucleolar fluorescence of Hep-2 cel ls pre-incubated 
with serum was seen wirh anti-vitronc:ctin an tibody. Aithou.s: h the 
signi ficance of this observation is unknown. it may signity char 
vitronectln is also involved in the removal of extracellular nuclear 
material. In funher fluorescence studies designed to elucidate the 
nJNre of the association of vitronecrin with keratin bodies. we 
demonstrated that vitronectin frolll serum bound to isolated KlFA, 
producing .. bright globular or ring-like pattern of staining of indi-
vidual KIFA with anti-vitronectin antibody. Bindingof vittOllCCr.in 
from sc:rum to KIFA material. shown on SOS-PAGE to consist of 
the four major recognized KIF proteins. was confirmed by immu-
noblotting. 
Because autoantibodies and complement proteins are frequently 
deposited on keratin bodies and on amyloid deposics in primary 
localized cutaneous amyloidosis in vivo 13,38], and keratin 61a-
ments are capable of activating complement 17,8). we wished co 
detcnninc wh.ether binding of vitronectin to KIFA was dependent 
on complement activation. As a necessary first step we showed that 
KIFA activate complement, because C3 was detected by immuno-
fluorescence on KIFA n::actcd with normal human serum but nOt 
wirh C4-deficient or hcat-inactivated sc.rum. Binding of vitronectin 
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Figure 3. ImmunoAuorescrncc staining of KlFA pre-incubated with nor-
m .. ! human $trum or pure vitronc:ctin with polydonal .mri-virronccrin anti-
body. Note bright homogeneous or ring-like fluorescence assocuted with 
Kif A usmg eith er (A) Ca++ buffer or (B) EOTA buffer. C: Fluoresccn~~ is 
absent when anti-vitroncctin antibody W;IS replaced by PBS. D: Posmve 
fluoresce ncr with anri-vitroneain antibody is prescnt when KIFA werc 
prc-incubated with heat-inactivated serum. E: Fluorescence of KIFA with 
anti-vitroncctin antibodies is secn when KJFA were pre-incubated with 
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Figure • . Arulysis of interaction of vicronectin with KIFA. 10111.'5 A and B: 
50S-PAGE sClioed with Coomassie Bluc; 1tH1~ e·G: immunobloning. Lan~ 
A : molecul::ar weight markers (0: phospory lase B, 92.5 kD: b: bovine serum 
albumin. 66.2 kD; c: ovalbwnin, 4S kD; J: carbonic anhydrase:. 31 kD); lont' 
B: SDS-PAGEof KlFA proteins (1 :65 kD: 2: 58 kD: 3: 56 kD: 4 : 50 kD): 
lo"t' C: idemmcation of KJFA proteins with ALI / AE) antikcratin antibod. 
ies;: ItHl~ D: immunoblotfing with aoti-vitroncctin of KIFA pre·incubated 
with normal human serum: 10'1~ E: immunoblotting of pure vitronectin with 
anri·virronecrin antibodies identi6es the characteristic 75- and 65·kD pro-
teins: lont' F: immunoblotting with ami-viuonectin antibodies of K1FA not 
previously reacted with serum; lon~ G: KIFA-serum reaction prod uct trans-
ferred to nitrocellulose incubated only with HRP·rabbit :a nti-mouse immu-
noglobulin anribody. 
from serum to KlFA was, however. independent of complemem 
activation because ir occurred even when C4·deficient or heat-inac-
tivated serum was used as rhe source of vitronectin. We have re-
cently reported that AP is fre1uently associated with keratin bodies 
in normal and lesional skin 9] as well as with amyloid deposits 
{32.39J. and thar SAP (which is identical co AP) binds [Q KlFA in a 
Ca++.dependem fashion [9]. W e excluded the possibiliry thar the 
binding of vitronectin to KlFA occurs via an interaction with AP by 
showing that vitronecnn binding to KlFA occurred in the absence 
of D++. Our demonstration that pure vitronectin also binds to 
KIFA provides definjtive evidence that the binding of virroDcctin to 
KlFA does not occur purely secondary to complement activation 
and docs nOt require the prest:nce of AP or of anti-keratin autoanti-
bodies. 
Production of apoptotic keratin bodies is nOt confined to lesional 
skin but occurs as a physiologic event in normal skin [1 J. Mecha-
nisms must therefore exist nor only for the removal of tite extracel-
lular keratin filament material but also to limit potential damage to 
adjacent " innocent bystander" cells as a result of complement acci· 
varion by keratin filaments [7 .8]. We have previously demonsrrated 
that fibroblasts and macrophages are capable ofingesring KlFA Pl. 
Vitronectin has been shown to promote the spreading and attach· 
ment of fibroblasts aad other cells [13 - 15J and also inhibits the 
cyto lytic membrane attack complex of complement [22.23]. Com-
plement-independent binding of vitronectin to KlFA (as demon-
strated in the present study), and to keratin bodies in vivo, nuy 
therefore play an imponant ro le not only in the removal of extracel-
lular keratin filaments by fibroblasts and/or macrophages but also in 
preventing excessive complement-mediated tissue destruction. 
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